Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis

Gastrointestinal Endoscopy

Volumn 53, Issue 1, 2001, Pages 33-39

  Testoni, P A ^a   Bagnolo, F ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ANESTHETIC AGENT; IOPAMIDOL; NONIONIC CONTRAST MEDIUM; PENTAZOCINE; PROPOFOL; SCOPOLAMINE BUTYL BROMIDE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; HUMAN; HYPERAMYLASEMIA; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PANCREATITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035141988     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2001.111390     Document Type: Article

References (23)

1. Complications of endoscopic sphincterotomy: A prospective study with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated ducts
2. Post-ERCP pancreatitis: Randomised, prospective study comparing a low- and high-osmolarity contrast agent
3. Endoscopic sphincterotomy-induced pancreatitis: Increased risk associated with nondilated bile duct and sphincter of Oddi dysfunction
4. Complications of endoscopic biliary sphincterotomy
5. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography
6. ERCP: Present practice in a single region
7. Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study
8. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis
9. Evaluation of post-ERCP pancreatitis: Potential causes noted during controlled study of differing contrast media
10. Use of corticosteroids in the prevention of post-ERCP pancreatitis
11. Endoscopic sphincterotomy complications and their management: An attempt at consensus
12. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes
13. Clinical outcome of post-ERCP pancreatitis: Relationship to history of previous pancreatitis
14. Post-ERCP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis
15. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis
16. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction
17. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques
18. Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy
19. 24-Hour serum amylase predicting pancreatic reaction after endoscopic biliary sphincterotomy
20. Pancreatitis or duodenal perforation after peri-Vaterian therapeutic endoscopic procedures: Diagnosis, differentiation, and management
21. A clinical based classification system for acute pancreatitis
22. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis
23. Post-ERCP pancreatitis: A comparative study of patients with and without pancreatic duct injection at the time of ERCP